Welcome to EQUITY DEVELOPMENT

The UK's longest established regulated provider of sponsored equity research.

We launched EQUITY DEVELOPMENT in 1997 becoming the first ever  regulated provider of Sponsored Equity Research in the UK.

Our research teams are made up of expert analysts with deep understanding & experience in their sectors.  Our research is distributed to all relevant investment classes & commentators. (at no cost to the reader).

We have made our name by specialising in those companies who are not receiving the attention that they merit, using detailed commentary, appropriate valuation metrics and regular publications to help eradicate undervaluation in the medium term.

 

FREE REGISTRATION

Sign up today and access the very latest company research

LOG IN

For access to all company research please

Phosphagenics

Phosphagenics is a biotechnology company with a diverse portfolio of technologies for improving the absorption, delivery and biological efficacy of a wide range of pharmaceutical and nutraceutical compounds.

 

Phosphagenics; commercial and scientific progress

  • Significant agreements announced with Alza and Nestle
  • Compound development proceeding – phase IIa study for TPM-01/Morphine starting
  • Fair valued retained at 41p-50p / share

Publication Date:
May 24 2006

Phosphagenics; leading the biotech revolution

  • Portfolio of revolutionary technologies
  • Multiple potential uses (pharma/nutraceutical)
  • Proven management
  • Good news flow expected in near future
  • Scope for multiple increase in capitalisation

Publication Date:
September 20 2005